← Back to Clinical Trials
Recruiting NCT06791447

NCT06791447 AI-Driven Prediction of Dialysis Outcome With EHR

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06791447
Status Recruiting
Phase
Sponsor The Eye Hospital of Wenzhou Medical University
Condition Dialysis Patients
Study Type OBSERVATIONAL
Enrollment 1,000,000 participants
Start Date 2023-01-01
Primary Completion 2025-05

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 100 Years
Study Type OBSERVATIONAL
Interventions
AI-assisted Predictive Model for Dialysis Outcomes

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000,000 participants in total. It began in 2023-01-01 with a primary completion date of 2025-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.

Eligibility Criteria

Inclusion Criteria: 1. Patients who have been undergoing dialysis (either hemodialysis or peritoneal dialysis) for at least 3 months. 2. Complete and accessible EHR data, including medical history, laboratory test results, dialysis treatment details, and clinical observations. 3. Participants must provide informed consent for the use of their health data for research purposes. Exclusion Criteria: 1. Patients with incomplete or missing critical EHR data, including medical history, laboratory results, dialysis data, or treatment details necessary for the study. 2. Patients who have been on dialysis for less than 3 months, to ensure stable data for outcome prediction.

Contact & Investigator

Central Contact

Fei Liu, MD

✉ liufei_2359@163.com

📞 +86 13810512704

Frequently Asked Questions

Who can join the NCT06791447 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 100 Years, studying Dialysis Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06791447 currently recruiting?

Yes, NCT06791447 is actively recruiting participants. Contact the research team at liufei_2359@163.com for enrollment information.

Where is the NCT06791447 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06791447 clinical trial?

NCT06791447 is sponsored by The Eye Hospital of Wenzhou Medical University. The trial plans to enroll 1,000,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology